Clinical Trials on Peripheral T-cell Lymphoma in New Zealand
Total 1607 results
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingT-cell Large Granular Lymphocyte Leukemia | T-cell Lymphomas | T-cell Prolymphocytic Leukemia | NK-Cell LymphomasUnited States
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
Eisai Inc.WithdrawnPeripheral T-Cell LymphomaUnited States
-
Angimmune LLCM.D. Anderson Cancer Center; Yale University; University of Texas Southwestern... and other collaboratorsCompletedMycosis Fungoides | Sezary Syndrome | T-cell Lymphomas | T-cell Leukemia | Cutaneous T-cell Lymphoma (CTCL)United States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
AbbVie (prior sponsor, Abbott)CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid LeukemiaUnited States, Canada
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
OnxeoTerminatedNon-Hodgkin's Lymphoma | Cutaneous T-Cell Lymphoma | Peripheral T-Cell LymphomaUnited States, Germany, Israel, France, Thailand
-
SciTech Development, LLCRush University Medical CenterRecruitingMycosis Fungoides | Cutaneous T-cell Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Cutaneous/Peripheral T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Classified | Primary Cutaneous T-cell Lymphoma | Cutaneous T-Cell Lymphoma, Unspecified | Follicular... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAngioimmunoblastic T-cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | Follicular T-Cell Lymphoma | Nodal Peripheral T-Cell Lymphoma...United States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
Deepa JagadeeshRecruitingAngioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Enteropathy Associated T-cell Lymphoma | Hepato-splenic T-cell Lymphoma | NK T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States, Australia
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Kura Oncology, Inc.CompletedRelapsed or Refractory Peripheral T-Cell LymphomaUnited States, Spain, Korea, Republic of
-
University of Medicine and Dentistry of New JerseyOrtho Biotech, Inc.Terminated
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAnaplastic Large Cell Lymphoma, ALK-Positive | Adult T-Cell Leukemia/Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic... and other conditionsUnited States, Canada
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Aileron Therapeutics, Inc.CompletedLymphoma | Solid Tumor | Peripheral T-Cell LymphomaUnited States
-
Kymera Therapeutics, Inc.RecruitingSolid Tumors | T-cell Prolymphocytic Leukemia (T-PLL) | Non Hodgkin Lymphoma (NHL) | Peripheral T-cell Lymphoma (PTCL) | Cutaneous T-Cell Lymphoma (CTCL) | Large Granular Lymphocytic Leukemia (LGL-L)United States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Completed
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
Far Eastern Memorial HospitalUnknownCutaneous T-cell LymphomaTaiwan
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
Ryan WilcoxUniversity of Michigan Rogel Cancer Center; TakedaActive, not recruitingLymphoma, T-Cell, PeripheralUnited States
-
CerRx, Inc.UnknownPeripheral T-cell LymphomaUnited States
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Yale UniversityMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Kyowa Kirin, Inc.Active, not recruitingCutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, RelapsedUnited States, United Kingdom, Spain, France, Italy
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
Yale UniversityCompletedT Cell LymphomaUnited States
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland